Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity. [electronic resource]
Producer: 20190130Description: 49-55 p. digitalISSN:- 1435-702X
- Angiogenesis Inhibitors -- administration & dosage
- Disease Progression
- Female
- Follow-Up Studies
- Gestational Age
- Humans
- Infant, Newborn
- Intravitreal Injections
- Male
- Ranibizumab -- administration & dosage
- Receptors, Vascular Endothelial Growth Factor -- administration & dosage
- Recombinant Fusion Proteins -- administration & dosage
- Retina -- pathology
- Retinopathy of Prematurity -- diagnosis
- Retrospective Studies
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.